Literature DB >> 11179162

Microbicides in HIV prevention.

S McCormack1, R Hayes, C J Lacey, A M Johnson.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11179162      PMCID： PMC1119634          DOI： 10.1136/bmj.322.7283.410

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  11 in total

1.  Condoms and seat belts: the parallels and the lessons.

Authors:  J Richens; J Imrie; A Copas
Journal:  Lancet       Date:  2000-01-29       Impact factor: 79.321

2.  Parameters of human immunodeficiency virus infection of human cervical tissue and inhibition by vaginal virucides.

Authors:  P Greenhead; P Hayes; P S Watts; K G Laing; G E Griffin; R J Shattock
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

3.  Low-efficacy HIV vaccines: potential for community-based intervention programmes.

Authors:  R M Anderson; G P Garnett
Journal:  Lancet       Date:  1996-10-12       Impact factor: 79.321

4.  Augmented HIV vaccine trial design for estimating reduction in infectiousness and protective efficacy.

Authors:  S Datta; M E Halloran; I M Longini
Journal:  Stat Med       Date:  1998-01-30       Impact factor: 2.373

5.  Understanding the epidemic of HIV in South Africa. Analysis of the antenatal clinic survey data.

Authors:  B Williams; C Campbell
Journal:  S Afr Med J       Date:  1998-03

Review 6.  From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection.

Authors:  D T Fleming; J N Wasserheit
Journal:  Sex Transm Infect       Date:  1999-02       Impact factor: 3.519

7.  An acceptability study of female-controlled methods of protection against HIV and STDs in south-western Uganda.

Authors:  R Pool; J A Whitworth; G Green; A K Mbonye; S Harrison; J Wilkinson; G J Hart
Journal:  Int J STD AIDS       Date:  2000-03       Impact factor: 1.359

8.  Safety study of nonoxynol-9 as a vaginal microbicide: evidence of adverse effects.

Authors:  M K Stafford; H Ward; A Flanagan; I J Rosenstein; D Taylor-Robinson; J R Smith; J Weber; V S Kitchen
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1998-04-01

9.  The effects of frequent nonoxynol-9 use on the vaginal and cervical mucosa.

Authors:  S Niruthisard; R E Roddy; S Chutivongse
Journal:  Sex Transm Dis       Date:  1991 Jul-Sep       Impact factor: 2.830

10.  Efficacy of nonoxynol 9 contraceptive sponge use in preventing heterosexual acquisition of HIV in Nairobi prostitutes.

Authors:  J Kreiss; E Ngugi; K Holmes; J Ndinya-Achola; P Waiyaki; P L Roberts; I Ruminjo; R Sajabi; J Kimata; T R Fleming
Journal:  JAMA       Date:  1992 Jul 22-29       Impact factor: 56.272
View more
  11 in total

1.  Preclinical safety assessments of UC781 anti-human immunodeficiency virus topical microbicide formulations.

Authors:  D L Patton; Y T Cosgrove Sweeney; J E Balkus; L C Rohan; B J Moncla; M A Parniak; S L Hillier
Journal:  Antimicrob Agents Chemother       Date:  2007-03-12       Impact factor: 5.191

Review 2.  Vaginal drug delivery systems for HIV prevention.

Authors:  Lisa Cencia Rohan; Alexandra B Sassi
Journal:  AAPS J       Date:  2009-02-05       Impact factor: 4.009

3.  Socioecological influences on community involvement in HIV vaccine research.

Authors:  Paula M Frew; Matthew Archibald; Brooke Hixson; Carlos del Rio
Journal:  Vaccine       Date:  2011-06-29       Impact factor: 3.641

4.  The future role of rectal and vaginal microbicides to prevent HIV infection in heterosexual populations: implications for product development and prevention.

Authors:  Marie-Claude Boily; Dobromir Dimitrov; Salim S Abdool Karim; Benoît Mâsse
Journal:  Sex Transm Infect       Date:  2011-12       Impact factor: 3.519

5.  An extended model of reasoned action to understand the influence of individual- and network-level factors on African Americans' participation in HIV vaccine research.

Authors:  Paula M Frew; Matthew Archibald; Dazon Dixon Diallo; Su-I Hou; Takeia Horton; Kayshin Chan; Mark J Mulligan; Carlos del Rio
Journal:  Prev Sci       Date:  2010-06

6.  Are women who work in bars, guesthouses and similar facilities a suitable study population for vaginal microbicide trials in Africa?

Authors:  Andrew Vallely; Ian R Hambleton; Stella Kasindi; Louise Knight; Suzanna C Francis; Tobias Chirwa; Dean Everett; Charles Shagi; Claire Cook; Celia Barberousse; Deborah Watson-Jones; John Changalucha; David Ross; Richard J Hayes
Journal:  PLoS One       Date:  2010-05-14       Impact factor: 3.240

7.  Evaluation of the lymphocyte trafficking drug FTY720 in vaginal tissues.

Authors:  Ai Tsuiki; Wei Luo; Tara Henning; Sundaram Vishwanathan; Chuong Dinh; Debra Adams; Elizabeth Sweeney; James Mitchell; Shannon Bachman; Prachi Sharma; Nathaniel Powell; Michael Hendry; Janet McNicholl; Ellen Kersh
Journal:  J Med Primatol       Date:  2013-01-12       Impact factor: 0.667

8.  An evaluation of intravaginal rings as a potential HIV prevention device in urban Kenya: behaviors and attitudes that might influence uptake within a high-risk population.

Authors:  Donna Jo Smith; Sabina Wakasiaka; Tina Dan My Hoang; Job Joab Bwayo; Carlos Del Rio; Frances H Priddy
Journal:  J Womens Health (Larchmt)       Date:  2008 Jul-Aug       Impact factor: 2.681

9.  Evaluations of unformulated and formulated dendrimer-based microbicide candidates in mouse and guinea pig models of genital herpes.

Authors:  D I Bernstein; L R Stanberry; S Sacks; N K Ayisi; Y H Gong; J Ireland; R J Mumper; G Holan; B Matthews; T McCarthy; N Bourne
Journal:  Antimicrob Agents Chemother       Date:  2003-12       Impact factor: 5.191

10.  RT-SHIV, an infectious CCR5-tropic chimeric virus suitable for evaluating HIV reverse transcriptase inhibitors in macaque models.

Authors:  Yonghou Jiang; Baoping Tian; Mohammed Saifuddin; Michael B Agy; Peter Emau; J Scott Cairns; Che-Chung Tsai
Journal:  AIDS Res Ther       Date:  2009-11-05       Impact factor: 2.250
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.